Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company committed to establishing tomorrow's standards of care in oncology and rare diseases, today announced that the first patient has ...

Debiopharm has randomised the first patient in the global Phase III clinical trial, OXTEND-III, to assess the safety and ...

That seemed to be the argument from Damian Hudson, the drug dealer on trial for killing an innocent mom in the crossfire of a ...

Here's why vegetarians face higher vitamin B12 deficiency risk, how it harms nerves, key symptoms to watch, and expert tips to prevent long-term neurological damage.

Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...

Vaccine advisers to the US Centers for Disease Control and Prevention are meeting today on what could be a major change to the childhood vaccination schedule. Follow here for live updates.

The FDA’s docket in December includes decisions for two big biologic franchises: BMS’s Breyanzi and Amgen’s Uplizna.

* Findings suggest a future treatment possibility for local injury that current antivenom cannot fully address ...

Advisers to the US Centers for Disease Control and Prevention (CDC) appear poised to consider questions about vaccine ...

A joint Singaporean-Chinese research team has developed an Evans Blue-modified lipid nanoparticle platform that directs mRNA ...

The nonprofit operating the controversial facilities doesn't track outcomes for patients experiencing cardiac arrest, strokes ...